Beyond market trends, investors keen on maximizing returns delve into the world of stock picking. The right selections can be instrumental in catapulting your wealth.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
The price of Outset Medical Inc (NASDAQ: OM) closed at $0.62 in the last session, down -1.13% from day before closing price of $0.63. In other words, the price has decreased by -$1.13 from its previous closing price. On the day, 2.49 million shares were traded. OM stock price reached its highest trading level at $0.68 during the session, while it also had its lowest trading level at $0.62.
Ratios:
We take a closer look at OM’s different ratios to gain a better understanding of the stock. For the most recent quarter (mrq), Quick Ratio is recorded 5.38 and its Current Ratio is at 6.80. In the meantime, Its Debt-to-Equity ratio is 2.95 whereas as Long-Term Debt/Eq ratio is at 2.92.
Upgrades & Downgrades
In addition, analysts’ ratings and any changes thereto give investors an idea of the stock’s future direction. In the most recent recommendation for the company, RBC Capital Mkts on August 08, 2024, Downgraded its rating to Sector Perform and sets its target price to $3 from $6 previously.
On June 21, 2024, RBC Capital Mkts Upgraded its rating to Outperform which previously was Sector Perform and also upped its target price recommendation from $5 to $6.
On April 08, 2024, BTIG Research started tracking the stock assigning a Buy rating and target price of $6.BTIG Research initiated its Buy rating on April 08, 2024, with a $6 target price.
Insider Transactions:
An investor can also benefit from insider trades by learning what management is thinking about the future direction of stock prices. A recent insider transaction in this stock occurred on Aug 15 ’24 when Trigg Leslie sold 5,308 shares for $0.84 per share. The transaction valued at 4,459 led to the insider holds 910,496 shares of the business.
Nash Marc sold 1,293 shares of OM for $1,086 on Aug 15 ’24. The SVP Operations and R&D now owns 239,397 shares after completing the transaction at $0.84 per share. On Aug 15 ’24, another insider, Brottem John L., who serves as the General Counsel of the company, sold 3,011 shares for $0.84 each. As a result, the insider received 2,529 and left with 230,295 shares of the company.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, OM now has a Market Capitalization of 32665506 and an Enterprise Value of 39750672. For the stock, the TTM Price-to-Sale (P/S) ratio is 0.28 while its Price-to-Book (P/B) ratio in mrq is 0.47. Its current Enterprise Value per Revenue stands at 0.341 whereas that against EBITDA is -0.275.
Stock Price History:
Over the past 52 weeks, OM has reached a high of $6.37, while it has fallen to a 52-week low of $0.44. The 50-Day Moving Average of the stock is 8.90%, while the 200-Day Moving Average is calculated to be -74.41%.
Shares Statistics:
According to the various share statistics, OM traded on average about 1.87M shares per day over the past 3-months and 581830 shares per day over the past 10 days. A total of 50.32M shares are outstanding, with a floating share count of 47.80M. Insiders hold about 8.24% of the company’s shares, while institutions hold 95.37% stake in the company. Shares short for OM as of 1728950400 were 3470550 with a Short Ratio of 1.86, compared to 1726185600 on 4386542. Therefore, it implies a Short% of Shares Outstanding of 3470550 and a Short% of Float of 7.8.
